Study suggests extending post-stenting DAPT beyond one year

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting “should be considered” in patients at low risk for bleeding, investigators for the OPTIDUAL trial recommend. Results of the trial were presented at ESC, held in August-September...